Max Healthcare Institute Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 819.62 | 664.26 | 747.88 |
| Operating Expense | 461.44 | 423.32 | 410.68 |
| Net Profit | 231.30 | 154.14 | 241.77 |
| Net Profit Margin | 28.22 | 23.20 | 32.33 |
| Earning Per Share | 2 | 1.59 | 2.49 |
| EBIDTA | 322.80 | 236.37 | 328.04 |
| Effective Tax Rate | 14.37 | 18.45 | 11.77 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 819.62 |
| Operating Expense | 461.44 |
| Net Profit | 231.30 |
| Net Profit Margin | 28.22 |
| Earning Per Share | 2.00 |
| EBIDTA | 322.80 |
| Effective Tax Rate | 14.37 |
Invest in Max Healthcare Institute Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,341.36 | 1,904.66 | 1,775.36 |
| Operating Expenses Annual | 1,579.32 | 1,320.57 | 1,332.10 |
| Operating Profit Annual | 1,033.26 | 728.26 | 571.38 |
| Interest Annual | 51.66 | 51.91 | 58.93 |
| Depreciation | 76.20 | 69.92 | 66.42 |
| Net Profit Annual | 687.26 | 694.31 | 331.52 |
| Tax Annual | 177.70 | -131.17 | 68.97 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,341.36 |
| Operating Expenses Annual | 1,579.32 |
| Operating Profit Annual | 1,033.26 |
| Interest Annual | 51.66 |
| Depreciation | 76.20 |
| Net Profit Annual | 687.26 |
| Tax Annual | 177.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1,157.69 | 214 | 597.77 |
| Cash Flow from Operations | 613.09 | 696.47 | 447.36 |
| Cash Flow from Investing | -805.64 | 301.69 | -669.65 |
| Cash Flow from Financing | -245.91 | -54.47 | -161.48 |
| Cash Flow at the End | 719.23 | 1,157.69 | 214 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1,157.69 |
| Cash Flow from Operations | 613.09 |
| Cash Flow from Investing | -805.64 |
| Cash Flow from Financing | -245.91 |
| Cash Flow at the End | 719.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 42.24 | 36.46 | 30.80 |
| PBIT Margin (%) | 37.47 | 30.79 | 24.76 |
| PBT Margin (%) | 36.74 | 30.20 | 24.34 |
| Net PROFIT Margin (%) | 28.10 | 34.76 | 17.87 |
| Return On Networth / Equity (%) | 9.34 | 10.40 | 5.41 |
| Return On Networth /Employed (%) | 11.64 | 8.49 | 6.89 |
| Return On Assets (%) | 8.71 | 9.73 | 5.00 |
| Total Debt / Equity (X) | 0.07 | 0.08 | 0.08 |
| Asset Turnover Ratio (%) | 0.31 | 0.28 | 0.28 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 42.24 |
| PBIT Margin (%) | 37.47 |
| PBT Margin (%) | 36.74 |
| Net PROFIT Margin (%) | 28.10 |
| Return On Networth / Equity (%) | 9.34 |
| Return On Networth /Employed (%) | 11.64 |
| Return On Assets (%) | 8.71 |
| Total Debt / Equity (X) | 0.07 |
| Asset Turnover Ratio (%) | 0.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 4,823.40 | 4,530.46 | 4,539.21 |
| Total Current Assets Annual | 1,026.76 | 1,436.05 | 712.44 |
| Non Current Assets Annual | 8,042.11 | 6,984.28 | 7,099.32 |
| Total Shareholders Funds Annual | 7,680.76 | 7,042.11 | 6,311.38 |
| Total Assets Annual | 9,068.87 | 8,420.33 | 7,811.76 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 4,823.40 |
| Total Current Assets Annual | 1,026.76 |
| Non Current Assets Annual | 8,042.11 |
| Total Shareholders Funds Annual | 7,680.76 |
| Total Assets Annual | 9,068.87 |
EPS (INR)
Expected
2.90
Reported
2.90
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
